PURPOSE: This study was designed to demonstrate the safety and functional performance of the LIFEBRIDGE B2T system (Medizintechnik GmbH, Ampfing, Germany), a novel portable life support system, during human applications under controlled conditions. DESCRIPTION: The LIFEBRIDGE system was used as a modular closed-circuit miniaturized cardiopulmonary bypass system for total support of circulation and gas exchange in a series of 8 elective coronary artery bypass grafting procedures using normothermic cardioplegic arrest. EVALUATION: Mean blood flow rates provided by the LIFEBRIDGE system were 4.82±0.47 L/min throughout the procedures (ie, 100% of calculated normal blood flow). Adequate gas exchange and arterial oxygenation were provided at all times. All patients survived the operations with no neurologic sequelae. CONCLUSIONS: The LIFEBRIDGE system provides sufficient circulatory support and gas exchange during cardiac arrest and apnea, which are the maximum stress conditions for a life support system. It is anticipated that the system will be widely used as a circulatory support system in future applications that require portability and rapid delivery of short-term mechanical circulatory support, such as with cardiogenic shock.
PURPOSE: This study was designed to demonstrate the safety and functional performance of the LIFEBRIDGE B2T system (Medizintechnik GmbH, Ampfing, Germany), a novel portable life support system, during human applications under controlled conditions. DESCRIPTION: The LIFEBRIDGE system was used as a modular closed-circuit miniaturized cardiopulmonary bypass system for total support of circulation and gas exchange in a series of 8 elective coronary artery bypass grafting procedures using normothermic cardioplegic arrest. EVALUATION: Mean blood flow rates provided by the LIFEBRIDGE system were 4.82±0.47 L/min throughout the procedures (ie, 100% of calculated normal blood flow). Adequate gas exchange and arterial oxygenation were provided at all times. All patients survived the operations with no neurologic sequelae. CONCLUSIONS: The LIFEBRIDGE system provides sufficient circulatory support and gas exchange during cardiac arrest and apnea, which are the maximum stress conditions for a life support system. It is anticipated that the system will be widely used as a circulatory support system in future applications that require portability and rapid delivery of short-term mechanical circulatory support, such as with cardiogenic shock.
Authors: Alexander Weymann; Bastian Schmack; Anton Sabashnikov; Christopher T Bowles; Philipp Raake; Rawa Arif; Markus Verch; Ursula Tochtermann; Jens Roggenbach; Aron Frederik Popov; Andre Ruediger Simon; Matthias Karck; Arjang Ruhparwar Journal: J Cardiothorac Surg Date: 2014-03-29 Impact factor: 1.637